Home
Atea Pharmaceuticals

Atea Pharmaceuticals Market Share Analysis for March 2026

Atea Pharmaceuticals is a leader in the discovery of oral direct-acting antiviral therapies, including our most advanced drug candidate, bemnifosbuvir (AT-527).

Health > Biotechnology and Pharmaceuticals

Domainateapharma.com

Year Founded2012

Employees51 - 200

Annual Revenue$200M - $500M

Atea Pharmaceuticals

Atea Pharmaceuticals (including company regionals)

ateapharma.com

See more website traffic and engagement information

Atea Pharmaceuticals Revenue up to March 2026 is 200M - 500M

revenue generated by Atea Pharmaceuticals top domains

Atea Pharmaceuticals top domains revenue over 3 years

Revenue for Atea Pharmaceuticals top domains

ateapharma.com200M - 500M

See more with Sales Intelligence

Total visits to Atea Pharmaceuticals's top domains

Understand Atea Pharmaceuticals market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

ateapharma.com3K

See more with Sales Intelligence

Avg. visit duration in Atea Pharmaceuticals's top domains

Analyze Atea Pharmaceuticals engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

ateapharma.com--

See more with Sales Intelligence

Avg. pageviews on Atea Pharmaceuticals's top domains

See how Atea Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

ateapharma.com1.23

See more with Sales Intelligence

Atea Pharmaceuticals top competitors by domain

Top similar sites in March 2026, ranked by their affinity

atea.comCompany NameAtea ASAEmployees5001 - 10000HQNorway, OsloAnnual revenue> $1BTotal visits348KComputers Electronics and Technology > Computer Hardware

Top technologies used by Atea Pharmaceuticals

These are the website technologies, by industry, used by Atea Pharmaceuticals top domains

Conversion & Analytics (2)

Google Analytics

Advertising (1)

PubMatic

Audio Video Media (1)

Vimeo

Business Solutions (1)

DocuSign

More Technologies

7

See all

News & Signals from Atea Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAtea Pharmaceuticals, Inc. attends event 8th Annual Evercore Healthcare Conference.Atea Pharmaceuticals to present at the 8th Annual Evercore Healthcare Conference.

NewsAtea Pharmaceuticals, Inc. attends event Morgan Stanley 23rd Annual Global Healthcare Conference.BOSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) - Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that members of the Atea management team will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9, 2025 at 1:05 p.m. ET in New York, NY.

NewsAtea Pharmaceuticals, Inc. attends event EASL Congress 2025.Atea Pharmaceuticals is presenting full Phase 2 data at the EASL Congress 2025, showing that bemnifosbuvir and ruzasvir met their primary endpoints.